Cargando…

A genetic polymorphism in P2RY(1) impacts response to clopidogrel in cats with hypertrophic cardiomyopathy

Clopidogrel is converted to its active metabolite by cytochrome P450 isoenzymes and irreversibly inhibits platelet activation by antagonizing the adenosine-diphosphate (ADP) receptor. It is frequently used in cats with hypertrophic cardiomyopathy (HCM) to prevent thromboembolic complications. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Yu, Li, Ronald H. L., Nguyen, Nghi, Ontiveros, Eric S., Kovacs, Samantha L., Oldach, Maureen S., Vernau, Karen M., Court, Michael H., Stern, Joshua A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206363/ https://www.ncbi.nlm.nih.gov/pubmed/34131167 http://dx.doi.org/10.1038/s41598-021-91372-3

Ejemplares similares

Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy
por: Oldach, Maureen S., et al.
Publicado: (2021)

Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study
por: Oldach, Maureen S., et al.
Publicado: (2019)

Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism
por: Li, Ronald H. L., et al.
Publicado: (2023)

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
por: Stern, Joshua A., et al.
Publicado: (2023)

Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet‐dependent thrombin generation in cats
por: Lo, Sara T., et al.
Publicado: (2023)

Pharmacokinetics of a single dose of Aficamten (CK‐274) on cardiac contractility in a A31P MYBPC3 hypertrophic cardiomyopathy cat model
por: Sharpe, Ashley N., et al.
Publicado: (2022)

Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
por: Sharpe, Ashley N., et al.
Publicado: (2023)

Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy
por: Walker, Ashley L., et al.
Publicado: (2022)

Heritability and Pedigree Analyses of Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca Mulatta)
por: Ueda, Yu, et al.
Publicado: (2021)

Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy
por: Visser, L.C., et al.
Publicado: (2017)

Prominent J wave in cats with hypertrophic cardiomyopathy
por: ELSHARKAWY, Samar H., et al.
Publicado: (2021)

Platelet Activation in Cats with Hypertrophic Cardiomyopathy
por: Tablin, F., et al.
Publicado: (2014)

Precision medicine identifies a pathogenic variant of the ITGA2B gene responsible for Glanzmann's thrombasthenia in a cat
por: Li, Ronald H. L., et al.
Publicado: (2020)

A One Health Approach to Hypertrophic Cardiomyopathy
por: Ueda, Yu, et al.
Publicado: (2017)

Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017)

Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)

Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy
por: Spalla, Ilaria, et al.
Publicado: (2019)

A Randomized Study Assessing the Effect of Diet in Cats with Hypertrophic Cardiomyopathy
por: Freeman, L.M., et al.
Publicado: (2014)

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy
por: Hori, Yasutomo, et al.
Publicado: (2018)

Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2021)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2022)

Comparative cardiac macroscopic and microscopic study in cats with hyperthyroidism vs. cats with hypertrophic cardiomyopathy
por: Janus, Izabela, et al.
Publicado: (2023)

Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy
por: Hanås, Sofia, et al.
Publicado: (2022)

Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy
por: SUGIMOTO, Keisuke, et al.
Publicado: (2020)

Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study
por: Novo Matos, Jose, et al.
Publicado: (2022)

Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy
por: Carvallo, Francisco R., et al.
Publicado: (2021)

Myocarditis caused by Feline Immunodeficiency Virus in Five Cats with Hypertrophic Cardiomyopathy
por: Rolim, V. Machado, et al.
Publicado: (2016)

Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy
por: Rohrbaugh, Michelle N., et al.
Publicado: (2020)

Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy
por: Borgeat, K., et al.
Publicado: (2014)

Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy
por: Seo, Joonbum, et al.
Publicado: (2020)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Sukumolanan, Pratch, et al.
Publicado: (2021)

Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome
por: Li, Miaonan, et al.
Publicado: (2017)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

Assessment of P2Y(12) Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation
por: Li, Ronald H. L., et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Platelet Activation and Clopidogrel Effects on ADP‐Induced Platelet Activation in Cats with or without the A31P Mutation in MYBPC3
por: Li, R.H.L., et al.
Publicado: (2016)

Evaluation of thrombin generation in dogs administered clopidogrel
por: Rank, Kaitlyn, et al.
Publicado: (2023)

Hypertension in the Setting of Hypertrophic Obstructive Cardiomyopathy and Cocaine Use
por: Miller, Daniel, et al.
Publicado: (2022)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sj9k750oop1t2tkr0rk4g76b0h